About: Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1996 (uk) article scientifique publié en 1996 (fr) im Januar 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1996 (ast) artikull shkencor i botuar më 01 janar 1996 (sq) scientific article published on 01 January 1996 (en)
publication date	wds:Q71801519-2FDE2B2D-93B0-4E68-A42D-DA580CFB6199
publication date	1996-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71801519-B3F1FC9E-EF29-485C-9918-BE255944DA5A wds:Q71801519-E3C5C11E-BF7B-4F29-9618-EF06EAC0EB03
author name string	I Wright G Camejo
rdfs:label	Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (en) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (nl) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (sq)
skos:prefLabel	Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (en) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (nl) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (sq)
name	Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (en) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (nl) Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (sq)
author	wds:Q71801519-048F215A-3E50-4DCF-A4FD-CE476203D615 wds:Q71801519-F36E9AAA-7408-4C97-8541-974C286A431B
author	Olov Wiklund Göran Bondjers
title	wds:Q71801519-C3653A24-6DBA-4F50-8017-FE3F7DD09A82
title	Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs (en)
page(s)	wds:Q71801519-16DDE636-9FCB-4AF0-933A-8E6756C77D9C
page(s)	57-67
instance of	wds:Q71801519-D304DD3D-242C-4C20-886D-4157E88F3DF0
instance of	scholarly article
PubMed ID	wds:Q71801519-EF358CED-6C69-4DF5-8B9D-3C63AEB04FFF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8929256
PubMed ID	8929256
published in	wds:Q71801519-392DB7F8-3E9A-454F-9EBD-02339461DF7D
published in	Atherosclerosis
issue	wds:Q71801519-B04CE1BB-651D-4FE6-9329-751D5995CD82
volume	wds:Q71801519-995CF693-A6A3-4C46-BCC3-6AD97D06D5F6
issue	1
volume	119
DOI	wds:Q71801519-F137954E-5194-423B-B9F3-81A80C727062
DOI	http://dx.doi.org/10.1016/0021-9150(95)05628-9
DOI	10.1016/0021-9150(95)05628-9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71801519
is cites work of	Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia. The extracellular matrix on atherogenesis and diabetes-associated vascular disease Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
is cites work of	wds:Q36013136-FFE93D22-98D0-4850-898D-7EC54CAE9905 wds:Q41060497-91DC94D0-4351-4E9F-99C6-40CC9FE95A58 wds:Q42471737-C0CF021D-69B9-4DC9-B97B-FB747797713B wds:Q34666829-42034FA7-F6CE-49B8-86CB-DA6A4A279135 wds:Q89389595-A97B97D4-6E1D-442A-8841-A7B28B80A114 wds:Q48534129-A1E36A76-B953-4A93-95A5-9711CA709DCA wds:Q77124466-335208E5-8EA0-496C-9BEA-CB518BD527DA wds:Q90608290-547C5C59-A5C5-4245-BC17-F69E7F6729F1 wds:Q42519995-292B2ED0-32F0-40A1-9080-8F5070AFDE20 wds:Q44789811-553B2AF5-681D-4A09-BCF1-010119DE66D2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software